Skip to main content
. 2024 Jan 15;25(2):1046. doi: 10.3390/ijms25021046

Figure 4.

Figure 4

TNB-928B structure: a fully humanized TCE with a bivalent arm for FRα and CD3 used to target FRα-over-expressing cancer cells.